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West AfricaThis issue of Travel Medicine and Infectious Disease has a
number of papers pertinent to infectious disease risks for
pilgrims attending Hajj, one of the largest annual recurring
mass gathering events that takes place in the Kingdom of
Saudi Arabia (KSA). The total number of pilgrims attending
the Hajj increased from 58,584 in 1920 to 3,161,573 in 2012
with about 1,752,932 from countries other than KSA [1].
The number of pilgrims received from each country is based
on the number of Muslims living in these countries. National
quotas are based on a ratio of 1000 visas per one million
people. To control the ever rising number of pilgrims
attending Hajj every year and to give priority to the
increasing number of awaiting international Muslims to
attend, Saudi nationals and local residents have to register
for the Hajj and Locals who have already performed the
Hajj are not issued permits for 5 years. The number of
Muslims and the average number of pilgrims from the four
countries in West Africa involved in the current Ebola Virus
Disease (EVD) outbreak are shown in Table 1.
The risk of the transmission of infectious diseases is
amplified during the Hajj due to the large number of
pilgrims, overcrowding and the presence of a large num-
ber of elderly pilgrims with comorbid diseases [1,2].
Previous outbreaks of infectious diseases such as menin-
gitis and food poisoning have occurred during the Hajj.
Each year there is an early coordination of efforts of
multiple KSA agencies in collaboration with international
organizations to identify any emerging or potential in-
fectious outbreak [2]. The occurrence of any public health
emergency of international concern (PHEIC) or the
emergence of any infectious disease outbreak any where
across the globe requiring notification by the International
Health Regulations (IHR), incite the public health au-
thority in KSA to takes extra-precautions to curtail the
introduction and subsequent spread of such infectious
diseases during the Hajj season. Careful review and con-
sultations with international agencies did not result in the
restriction of any pilgrims due to the emergence of the
Middle East Respiratory Syndrome coronavirus (MERS-CoV)
in 2012e2014 [2]. There were no travel restrictions due tohttp://dx.doi.org/10.1016/j.tmaid.2014.09.003
1477-8939/ª 2014 Elsevier Ltd. All rights reserved.MERS, however the Saudi ministry of health recommended
that older adults (>65 years of age), children, and those
immunocompromized or with chronic medical conditions
should postpone the Hajj for 2012e2014.
EVD has been recently detected in West Africa with the
largest outbreak ever in the history of this disease ignited
by the first case which was reported from Guinea in
December 2013. As of August 28, 2014. Ebola had caused a
total of 3069, with 1552 deaths in Guinea, Liberia, Nigeria,
and Sierra Leone (Fig. 1). In the last three weeks, >40% of
the total number of cases occurred. The World Health Or-
ganization (WHO) Director General declared the outbreak a
PHEIC on August 8, 2014 after 2 days of deliberation by the
IHR emergency committee [3]. Another outbreak was re-
ported on August 26, 2014 in Democratic Republic of Congo
(DRC) and was not related to the other West African
countries [4]. And Senegal confirmed its 1st case of EVD on
Friday 29 Aug 2014, according to a statement from its
Health Minister. The patient, a Guinean national who
traveled to Senegal, is in quarantine [5]. Currently, the high
case fatality rate, the lack of approved preventative vac-
cines and specific therapy for EVD is magnifying the global
public health concern. An experimental therapy (Zmapp)
was tried in a few patients with Ebola and subsequently on
August 12, 2014 an expert panel for the WHO considered it
is ethical to use an unproven intervention for the treatment
or prevention of the Ebola virus [6].
Ebola is highly contagious zoonotic disease caused by a
virus of the family Filoviridae, whose members comprise 2
genera of enveloped, negative, single-stranded RNA vi-
ruses: Marburgvirus and Ebolavirus. The incubation period
of Ebola ranges from 2 to 21 days, and can present initially
with nonspecific symptoms such as fever, chills, myalgia,
malaise, respiratory and gastrointestinal symptoms fol-
lowed later by hemorrhagic symptoms in severe cases. The
disease is transmitted by close contact and upon exposure
to infected blood and body fluid. All global health author-
ities agree that preventing the Ebola spread once diagnosed
is possible if human medical capacity and effective pro-
tective measures are applied.
Table 1 Number of Muslims (percentage of the total
population) and the average number of pilgrims in the last
two years from Liberia, Nigeria, Guinea and Sierra Leone.
Country Country
Population
Number (%) of
Muslim
Population
Average Number
of Pilgrims in
the Last Two Years
Liberia 3,990,000 483000 (12.2) 244
Sierra
Leone
5,870,000 4059 (71.3) 952
Nigeria 158,420,000 78513000 (50.4) 87550
Guinea 9,980,000 8502000 (84.4) 8221
416 EditorialThe 2014 Hajj season will take place from October 1 to
6th. And long before the WHO announcement about PHEIC,
the Saudi MOH after careful review by its national infec-
tious diseases committee had asked in April 2014 that the
respective authorities to suspend issuing the Hajj and
Umrah’s visas for the people of Guinea, Sierra Leone and
Liberia [2,7]. Based on risk assessment in 2012, the Saudi
Ministry of Health excluded pilgrims from Uganda and the
Democratic Republic of the Congo due to the occurrence of
an Ebola outbreak at that time [8]. A mathematical
modeling of the risk of Ebola introduction from the Uganda
outbreak in 2012 during Hajj was estimated to have a mean
risk of 8.9  1014 (SD Z 6.9  1014) and thought to be
negligible [9]. Despite the low risk, the introduction of a
single case of Ebola during the Hajj would have a cata-
strophic consequences for the global health community.
Therefor, it is imperative to prevent any such event and
take strict preemptive measures for the prevention of Ebola
importation to the Hajj. The Saudi Ministry of Health public
health staff who are stationed at all ports of entry into KSAFigure 1 Number of probable, suspect and confirmed cases
of Ebola and death (According to WHO: http://www.who.int/
csr/don/2014_08_28_ebola/en/).have been trained to observe all arriving pilgrims for any
signs or symptoms of infectious diseases requiring medical
assessment and/or quarantine by the local public health
authorities. They have gained significant experience from
the decades of monitoring incoming and departing millions
of pilgrims from more than 184 countries. The Saudi MOH
and the US CDC had called to postpone non-essential trips
to the most affected West African countries (Guinea, Sierra
Leone, and Liberia) in order to prevent the spread of EVD
beyond the boundaries of these countries.
KSA provides free health care for all pilgrims at the Hajj
premises through 25 hospitals, 4427 beds including 500
critical care beds and 550 emergency care beds [8]. The
availability of 141 healthcare centers in the Hajj area
staffed with 20,000 specialized healthcare workers further
enhance the provision of healthcare for the pilgrims [8].
Since EVD spreads mainly between individuals through
direct and indirect contact with blood and body fluid, the
focus to limit the introduction of the virus and its spread
depends on three key elements: high level of vigilance to
detect cases early, proper isolation and contact tracing and
strict application of appropriate infection control standards
with ample supplies of all personal protective equipment
(PPE) to be used in the correct way constantly. The provi-
sion of enough supply and training of HCWs on the correct
use of PPE are priorities for the control of the EVD outbreak
without overuse or underuse [10].
The challenges facing mass gathering (MG) planners in
dealing with Ebola will be multiple folds: including finding
a simple syndromic surveillance mechanism/criteria that
will be sensitive and specific enough to pick up highly
suspected cases, development of point of care testing to
confirm or rule out suspected cases, the ability to do
effective contact tracing and quarantining of suspected
cases and their extensive contacts which will disrupt the
strict schedule of many of the MG attendees. In addition,
lack of effective and approved preventative or thera-
peutic modalities and communication challenges to
overcome the panic that such a disease with a very high
mortality rate will generate add further challenges. Very
elaborate and comprehensive plans need to be drawn up
in advance involving all national, regional and interna-
tional stakeholders to ensure smooth and effective
execution at the time of any MG event. As Hajj is the
largest recurring MG event in the world, planning for the
Hajj each year starts immediately after completing the
previous Hajj season. These preparatory plans had
evolved over many years with unlimited government
financial and logistical support with significant investment
in establishing an extensive infrastructure, a cadre of
highly trained human resources and deeply established
networks, coordination and national, regional and inter-
national collaboration. The above investment in devel-
oping a state-of-the art global center for mass gathering
medicine with all its global partners will be best fitted to
face the current challenge and any future emerging in-
fectious diseases challenges.
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